211 related articles for article (PubMed ID: 24464841)
1. Inhibitory activities of trichostatin a in U87 glioblastoma cells and tumorsphere-derived cells.
Sassi Fde A; Caesar L; Jaeger M; Nör C; Abujamra AL; Schwartsmann G; de Farias CB; Brunetto AL; Lopez PL; Roesler R
J Mol Neurosci; 2014 Sep; 54(1):27-40. PubMed ID: 24464841
[TBL] [Abstract][Full Text] [Related]
2. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
[TBL] [Abstract][Full Text] [Related]
3. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells.
Alvarez AA; Field M; Bushnev S; Longo MS; Sugaya K
J Mol Neurosci; 2015 Jan; 55(1):7-20. PubMed ID: 24874578
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase inhibitors exert anti-tumor effects on human adherent and stem-like glioma cells.
Was H; Krol SK; Rotili D; Mai A; Wojtas B; Kaminska B; Maleszewska M
Clin Epigenetics; 2019 Jan; 11(1):11. PubMed ID: 30654849
[TBL] [Abstract][Full Text] [Related]
5. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of histone deacetylases sensitizes glioblastoma cells to lomustine.
Staberg M; Michaelsen SR; Rasmussen RD; Villingshøj M; Poulsen HS; Hamerlik P
Cell Oncol (Dordr); 2017 Feb; 40(1):21-32. PubMed ID: 27766591
[TBL] [Abstract][Full Text] [Related]
7. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
Höring E; Podlech O; Silkenstedt B; Rota IA; Adamopoulou E; Naumann U
Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
[TBL] [Abstract][Full Text] [Related]
9. Suberoylanilide hydroxamic acid represses glioma stem-like cells.
Hsu CC; Chang WC; Hsu TI; Liu JJ; Yeh SH; Wang JY; Liou JP; Ko CY; Chang KY; Chuang JY
J Biomed Sci; 2016 Nov; 23(1):81. PubMed ID: 27863490
[TBL] [Abstract][Full Text] [Related]
10. Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
Chikamatsu K; Ishii H; Murata T; Sakakura K; Shino M; Toyoda M; Takahashi K; Masuyama K
Cancer Sci; 2013 Nov; 104(11):1468-75. PubMed ID: 23992541
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
Marampon F; Leoni F; Mancini A; Pietrantoni I; Codenotti S; Ferella L; Megiorni F; Porro G; Galbiati E; Pozzi P; Mascagni P; Budillon A; Maggio R; Tombolini V; Fanzani A; Gravina GL; Festuccia C
J Cancer Res Clin Oncol; 2019 Feb; 145(2):393-409. PubMed ID: 30474756
[TBL] [Abstract][Full Text] [Related]
12. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G
Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406
[TBL] [Abstract][Full Text] [Related]
13. A novel histone deacetylase inhibitor, CKD5, has potent anti-cancer effects in glioblastoma.
Choi SA; Kwak PA; Park CK; Wang KC; Phi JH; Lee JY; Lee CS; Lee JH; Kim SK
Oncotarget; 2017 Feb; 8(6):9123-9133. PubMed ID: 27852054
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin B in cervical cancer: critical for the maintenance of cancer stem-like cell characters.
Tian Y; Ding W; Wang Y; Ji T; Sun S; Mo Q; Chen P; Fang Y; Liu J; Wang B; Zhou J; Ma D; Wu P
PLoS One; 2013; 8(12):e84457. PubMed ID: 24367661
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors repress chondrosarcoma cell proliferation.
Zhu J; Gu J; Ma J; Xu Z; Tao H
J BUON; 2015; 20(1):269-74. PubMed ID: 25778327
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of Large-Conductance Calcium-Activated Potassium Channels in Human Glioblastoma Stem-Like Cells and Their Role in Cell Migration.
Rosa P; Sforna L; Carlomagno S; Mangino G; Miscusi M; Pessia M; Franciolini F; Calogero A; Catacuzzeno L
J Cell Physiol; 2017 Sep; 232(9):2478-2488. PubMed ID: 27606467
[TBL] [Abstract][Full Text] [Related]
17. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells.
Duncan HF; Smith AJ; Fleming GJ; Cooper PR
J Endod; 2012 Mar; 38(3):339-45. PubMed ID: 22341071
[TBL] [Abstract][Full Text] [Related]
19. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
Svechnikova I; Almqvist PM; Ekström TJ
Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
[TBL] [Abstract][Full Text] [Related]
20. The effects of type I interferon on glioblastoma cancer stem cells.
Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
